| Publisher |
Taylor & Francis |
| Agreement ID | tf2024jisc |
| Agreement labeling | Taylor and Francis Read and Publish 2024-25 |
| Has the agreement been disclosed and published? | Yes |
| URL | https://subscriptionsmanager.jisc.ac.uk/ catalogue/3040 |
| Agreement period | 01/01/2024 – 12/31/2025 |
| Consortia / Institution | Jisc |
| Country | United Kingdom |
| SIZE
Approximate range of annual corresponding author publications |
6000 |
| Comments on size/article output | Number above based on prior 3 year’s data but new agreement includes fully OA titles, F1000 and Routledge Open so is likely an underestimate |
| COSTS
How do the costs of the agreement relate to previous subscription-only agreements with the publisher? |
Cost increase |
| Comments on cost development | Cost based on previous subscription element only but including 2.99% p.a. increase, prior publishing not priced in additionally |
| FINANCIAL SHIFT
Transformative agreements vary by their transformative mechanisms, meaning the way in which financing is shifted from the subscription side to open access publishing. What are the characteristics of this agreement to this regard? |
Subscriptions partly converted to OA publishing fees |
| RISK SHARING
How do entitlements for open access publishing correlate to the anticipated article output? Which mechanisms for risk sharing have been agreed in cases of exceeding or not reaching the number of OA publishing entitlements? |
The buffer provided is generous and includes an additional 10% gratis article allocation. Above the cap the risk is borne by institutions although the publisher intends this to be a “no article left behind” agreement. |
| OA COVERAGE
Are all journals relevant to your affiliated authors (in which you expect them to publish) eligible for OA publishing under the agreement? |
Yes |
| Are fully open access journals covered by the agreement? | Yes |
| OA LICENSE | CC-BY preference, exceptions allowed |
| ARTICLE TYPES |
Original research articles Review articles Method Articles, Antibody Validation Articles, Systematic reviews, Clinical Practice Articles, Case Reports, Opinion Articles |
| ACCESS COSTS
What is the approximate share of access related costs of the overall agreement? |
20%-50% |
| ACCESS COVERAGE
Are all read relevant journals covered by the agreement? |
Yes |
| PERPETUAL ACCESS RIGHTS | Yes |
| WORKFLOW ASSESSMENT | Too early to assess |
| OVERALL ASSESSMENT AND COMMENTS |
Impact on overall OA transition globally is small. Cost and operation is sustainable although in future an agreement based purely on publishing services rendered, transparently priced would be preferable rather than one based on historic print spend.
Overall we would say that, in the absence of a significant change in researcher publishing behavior, this is the best agreement we could get from T&F. |
| Request contact to the licensee | contact [at] esac-initiative [dot] org |